Wednesday, February, 15, 2012

Small Cell Lung Cancer

Featured Article

References


  • U.S. Food and Drugs Administration. Alert for Healthcare Professionals: Iressa (gefitinib).
  • Fehrenbacher L. A Phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety bevacizumab in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride compared with chemotherapy alone for treatment of recurrent or refractory NSCLC. Proceedings from the 42nd Annual Meeting of the American Society for Clinical Oncology. Atlanta, GA. June...
Read more

More information on "Small Cell Lung Cancer"

From Our Sources

More on COPD ยป